-
Je něco špatně v tomto záznamu ?
Trypanocidal action of bisphosphonium salts through a mitochondrial target in bloodstream form Trypanosoma brucei
AA. Alkhaldi, J. Martinek, B. Panicucci, C. Dardonville, A. Zíková, HP. de Koning,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011 do 2020
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-12-01
Elsevier Open Access Journals
od 2011-12-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
- MeSH
- adenosintrifosfát metabolismus MeSH
- azidy farmakologie MeSH
- buněčné linie MeSH
- membránový potenciál mitochondrií účinky léků MeSH
- mitochondriální DNA metabolismus MeSH
- mitochondrie účinky léků genetika metabolismus MeSH
- organofosforové sloučeniny chemie farmakologie MeSH
- protonové ATPasy metabolismus MeSH
- RNA interference MeSH
- sukcinátdehydrogenasa metabolismus MeSH
- trypanocidální látky farmakologie MeSH
- Trypanosoma brucei brucei cytologie účinky léků růst a vývoj MeSH
- trypanozomóza africká parazitologie MeSH
- vápník metabolismus MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Lipophilic bisphosphonium salts are among the most promising antiprotozoal leads currently under investigation. As part of their preclinical evaluation we here report on their mode of action against African trypanosomes, the etiological agents of sleeping sickness. The bisphosphonium compounds CD38 and AHI-9 exhibited rapid inhibition of Trypanosoma brucei growth, apparently the result of cell cycle arrest that blocked the replication of mitochondrial DNA, contained in the kinetoplast, thereby preventing the initiation of S-phase. Incubation with either compound led to a rapid reduction in mitochondrial membrane potential, and ATP levels decreased by approximately 50% within 1 h. Between 4 and 8 h, cellular calcium levels increased, consistent with release from the depolarized mitochondria. Within the mitochondria, the Succinate Dehydrogenase complex (SDH) was investigated as a target for bisphosphonium salts, but while its subunit 1 (SDH1) was present at low levels in the bloodstream form trypanosomes, the assembled complex was hardly detectable. RNAi knockdown of the SDH1 subunit produced no growth phenotype, either in bloodstream or in the procyclic (insect) forms and we conclude that in trypanosomes SDH is not the target for bisphosphonium salts. Instead, the compounds inhibited ATP production in intact mitochondria, as well as the purified F1 ATPase, to a level that was similar to 1 mM azide. Co-incubation with azide and bisphosphonium compounds did not inhibit ATPase activity more than either product alone. The results show that, in T. brucei, bisphosphonium compounds do not principally act on succinate dehydrogenase but on the mitochondrial FoF1 ATPase.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000293
- 003
- CZ-PrNML
- 005
- 20170118120635.0
- 007
- ta
- 008
- 170103s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpddr.2015.12.002 $2 doi
- 024 7_
- $a 10.1016/j.ijpddr.2015.12.002 $2 doi
- 035 __
- $a (PubMed)27054061
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Alkhaldi, Abdulsalam A M $u Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom. $7 gn_A_00004348
- 245 10
- $a Trypanocidal action of bisphosphonium salts through a mitochondrial target in bloodstream form Trypanosoma brucei / $c AA. Alkhaldi, J. Martinek, B. Panicucci, C. Dardonville, A. Zíková, HP. de Koning,
- 520 9_
- $a Lipophilic bisphosphonium salts are among the most promising antiprotozoal leads currently under investigation. As part of their preclinical evaluation we here report on their mode of action against African trypanosomes, the etiological agents of sleeping sickness. The bisphosphonium compounds CD38 and AHI-9 exhibited rapid inhibition of Trypanosoma brucei growth, apparently the result of cell cycle arrest that blocked the replication of mitochondrial DNA, contained in the kinetoplast, thereby preventing the initiation of S-phase. Incubation with either compound led to a rapid reduction in mitochondrial membrane potential, and ATP levels decreased by approximately 50% within 1 h. Between 4 and 8 h, cellular calcium levels increased, consistent with release from the depolarized mitochondria. Within the mitochondria, the Succinate Dehydrogenase complex (SDH) was investigated as a target for bisphosphonium salts, but while its subunit 1 (SDH1) was present at low levels in the bloodstream form trypanosomes, the assembled complex was hardly detectable. RNAi knockdown of the SDH1 subunit produced no growth phenotype, either in bloodstream or in the procyclic (insect) forms and we conclude that in trypanosomes SDH is not the target for bisphosphonium salts. Instead, the compounds inhibited ATP production in intact mitochondria, as well as the purified F1 ATPase, to a level that was similar to 1 mM azide. Co-incubation with azide and bisphosphonium compounds did not inhibit ATPase activity more than either product alone. The results show that, in T. brucei, bisphosphonium compounds do not principally act on succinate dehydrogenase but on the mitochondrial FoF1 ATPase.
- 650 _2
- $a adenosintrifosfát $x metabolismus $7 D000255
- 650 _2
- $a azidy $x farmakologie $7 D001386
- 650 _2
- $a vápník $x metabolismus $7 D002118
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a mitochondriální DNA $x metabolismus $7 D004272
- 650 _2
- $a membránový potenciál mitochondrií $x účinky léků $7 D053078
- 650 _2
- $a mitochondrie $x účinky léků $x genetika $x metabolismus $7 D008928
- 650 _2
- $a organofosforové sloučeniny $x chemie $x farmakologie $7 D009943
- 650 _2
- $a protonové ATPasy $x metabolismus $7 D006180
- 650 _2
- $a RNA interference $7 D034622
- 650 _2
- $a sukcinátdehydrogenasa $x metabolismus $7 D013385
- 650 _2
- $a trypanocidální látky $x farmakologie $7 D014344
- 650 _2
- $a Trypanosoma brucei brucei $x cytologie $x účinky léků $x růst a vývoj $7 D014346
- 650 _2
- $a trypanozomóza africká $x parazitologie $7 D014353
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Martinek, Jan $u Institute of Parasitology, Biology Centre & Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
- 700 1_
- $a Panicucci, Brian $u Institute of Parasitology, Biology Centre & Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
- 700 1_
- $a Dardonville, Christophe $u Instituto de Química Médica, IQM-CSIC, Juan de la Cierva 3, E-28006 Madrid, Spain.
- 700 1_
- $a Zíková, Alena $u Institute of Parasitology, Biology Centre & Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
- 700 1_
- $a de Koning, Harry P $u Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
- 773 0_
- $w MED00184051 $t International journal for parasitology. Drugs and drug resistance $x 2211-3207 $g Roč. 6, č. 1 (2016), s. 23-34
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27054061 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170118120742 $b ABA008
- 999 __
- $a ok $b bmc $g 1179433 $s 960860
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 6 $c 1 $d 23-34 $e 20151211 $i 2211-3207 $m International journal for parasitology. Drugs and drug resistance $n Int J Parasitol Drugs Drug Resist $x MED00184051
- LZP __
- $a Pubmed-20170103